These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 27043267)

  • 1. Identification of N-phenyl-2-(N-phenylphenylsulfonamido)acetamides as new RORγ inverse agonists: Virtual screening, structure-based optimization, and biological evaluation.
    Song Y; Xue X; Wu X; Wang R; Xing Y; Yan W; Zhou Y; Qian CN; Zhang Y; Xu Y
    Eur J Med Chem; 2016 Jun; 116():13-26. PubMed ID: 27043267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of 2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide derivatives as new RORγ inhibitors using virtual screening, synthesis and biological evaluation.
    Zhang Y; Xue X; Jin X; Song Y; Li J; Luo X; Song M; Yan W; Song H; Xu Y
    Eur J Med Chem; 2014 May; 78():431-41. PubMed ID: 24704616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and structural optimization of 4-(4-(benzyloxy)phenyl)-3,4-dihydropyrimidin-2(1H)-ones as RORc inverse agonists.
    Wu XS; Wang R; Xing YL; Xue XQ; Zhang Y; Lu YZ; Song Y; Luo XY; Wu C; Zhou YL; Jiang JQ; Xu Y
    Acta Pharmacol Sin; 2016 Nov; 37(11):1516-1524. PubMed ID: 27374490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel pyrazole-containing benzamides as potent RORγ inverse agonists.
    Wang T; Banerjee D; Bohnert T; Chao J; Enyedy I; Fontenot J; Guertin K; Jones H; Lin EY; Marcotte D; Talreja T; Van Vloten K
    Bioorg Med Chem Lett; 2015 Aug; 25(15):2985-90. PubMed ID: 26048789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent and Orally Bioavailable Inverse Agonists of RORγt Resulting from Structure-Based Design.
    Narjes F; Xue Y; von Berg S; Malmberg J; Llinas A; Olsson RI; Jirholt J; Grindebacke H; Leffler A; Hossain N; Lepistö M; Thunberg L; Leek H; Aagaard A; McPheat J; Hansson EL; Bäck E; Tångefjord S; Chen R; Xiong Y; Hongbin G; Hansson TG
    J Med Chem; 2018 Sep; 61(17):7796-7813. PubMed ID: 30095900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of 1-{4-[3-fluoro-4-((3s,6r)-3-methyl-1,1-dioxo-6-phenyl-[1,2]thiazinan-2-ylmethyl)-phenyl]-piperazin-1-yl}-ethanone (GNE-3500): a potent, selective, and orally bioavailable retinoic acid receptor-related orphan receptor C (RORc or RORγ) inverse agonist.
    Fauber BP; René O; Deng Y; DeVoss J; Eidenschenk C; Everett C; Ganguli A; Gobbi A; Hawkins J; Johnson AR; La H; Lesch J; Lockey P; Norman M; Ouyang W; Summerhill S; Wong H
    J Med Chem; 2015 Jul; 58(13):5308-22. PubMed ID: 26061388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural determinant for inducing RORgamma specific inverse agonism triggered by a synthetic benzoxazinone ligand.
    Marcotte DJ; Liu Y; Little K; Jones JH; Powell NA; Wildes CP; Silvian LF; Chodaparambil JV
    BMC Struct Biol; 2016 Jun; 16(1):7. PubMed ID: 27246200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzoxazepines Achieve Potent Suppression of IL-17 Release in Human T-Helper 17 (TH 17) Cells through an Induced-Fit Binding Mode to the Nuclear Receptor RORγ.
    Olsson RI; Xue Y; von Berg S; Aagaard A; McPheat J; Hansson EL; Bernström J; Hansson P; Jirholt J; Grindebacke H; Leffler A; Chen R; Xiong Y; Ge H; Hansson TG; Narjes F
    ChemMedChem; 2016 Jan; 11(2):207-16. PubMed ID: 26553345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and Characterization of XY101, a Potent, Selective, and Orally Bioavailable RORγ Inverse Agonist for Treatment of Castration-Resistant Prostate Cancer.
    Zhang Y; Wu X; Xue X; Li C; Wang J; Wang R; Zhang C; Wang C; Shi Y; Zou L; Li Q; Huang Z; Hao X; Loomes K; Wu D; Chen HW; Xu J; Xu Y
    J Med Chem; 2019 May; 62(9):4716-4730. PubMed ID: 30964293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and structure activity relationships of quinoline tertiary alcohol modulators of RORγt.
    Kummer DA; Cummings MD; Abad M; Barbay J; Castro G; Wolin R; Kreutter KD; Maharoof U; Milligan C; Nishimura R; Pierce J; Schalk-Hihi C; Spurlino J; Urbanski M; Venkatesan H; Wang A; Woods C; Xue X; Edwards JP; Fourie AM; Leonard K
    Bioorg Med Chem Lett; 2017 May; 27(9):2047-2057. PubMed ID: 28318945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of biaryl carboxylamides as potent RORγ inverse agonists.
    Chao J; Enyedy I; Van Vloten K; Marcotte D; Guertin K; Hutchings R; Powell N; Jones H; Bohnert T; Peng CC; Silvian L; Hong VS; Little K; Banerjee D; Peng L; Taveras A; Viney JL; Fontenot J
    Bioorg Med Chem Lett; 2015 Aug; 25(15):2991-7. PubMed ID: 26048806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of N-sulfonyl-tetrahydroquinolines as RORc inverse agonists.
    Fauber BP; Gobbi A; Savy P; Burton B; Deng Y; Everett C; La H; Johnson AR; Lockey P; Norman M; Wong H
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4109-13. PubMed ID: 26321361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of biaryls as RORγ inverse agonists by using structure-based design.
    Enyedy IJ; Powell NA; Caravella J; van Vloten K; Chao J; Banerjee D; Marcotte D; Silvian L; McKenzie A; Hong VS; Fontenot JD
    Bioorg Med Chem Lett; 2016 May; 26(10):2459-2463. PubMed ID: 27080181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of phenoxyindazoles and phenylthioindazoles as RORγ inverse agonists.
    Ouvry G; Bouix-Peter C; Ciesielski F; Chantalat L; Christin O; Comino C; Duvert D; Feret C; Harris CS; Lamy L; Luzy AP; Musicki B; Orfila D; Pascau J; Parnet V; Perrin A; Pierre R; Polge G; Raffin C; Rival Y; Taquet N; Thoreau E; Hennequin LF
    Bioorg Med Chem Lett; 2016 Dec; 26(23):5802-5808. PubMed ID: 27815118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and Characterization of CD12681, a Potent RORγ Inverse Agonist, Preclinical Candidate for the Topical Treatment of Psoriasis.
    Ouvry G; Atrux-Tallau N; Bihl F; Bondu A; Bouix-Peter C; Carlavan I; Christin O; Cuadrado MJ; Defoin-Platel C; Deret S; Duvert D; Feret C; Forissier M; Fournier JF; Froude D; Hacini-Rachinel F; Harris CS; Hervouet C; Huguet H; Lafitte G; Luzy AP; Musicki B; Orfila D; Ozello B; Pascau C; Pascau J; Parnet V; Peluchon G; Pierre R; Piwnica D; Raffin C; Rossio P; Spiesse D; Taquet N; Thoreau E; Vatinel R; Vial E; Hennequin LF
    ChemMedChem; 2018 Feb; 13(4):321-337. PubMed ID: 29327456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RORγ antagonists and inverse agonists: a patent review.
    Bronner SM; Zbieg JR; Crawford JJ
    Expert Opin Ther Pat; 2017 Jan; 27(1):101-112. PubMed ID: 27629281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulators of the nuclear receptor retinoic acid receptor-related orphan receptor-γ (RORγ or RORc).
    Fauber BP; Magnuson S
    J Med Chem; 2014 Jul; 57(14):5871-92. PubMed ID: 24502334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cardenolides strophanthidin, digoxigenin and dihydroouabain act as activators of the human RORγ/RORγT receptors.
    Karaś K; Sałkowska A; Walczak-Drzewiecka A; Ryba K; Dastych J; Bachorz RA; Ratajewski M
    Toxicol Lett; 2018 Oct; 295():314-324. PubMed ID: 29981919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural studies unravel the active conformation of apo RORγt nuclear receptor and a common inverse agonism of two diverse classes of RORγt inhibitors.
    Li X; Anderson M; Collin D; Muegge I; Wan J; Brennan D; Kugler S; Terenzio D; Kennedy C; Lin S; Labadia ME; Cook B; Hughes R; Farrow NA
    J Biol Chem; 2017 Jul; 292(28):11618-11630. PubMed ID: 28546429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationship-guided development of retinoic acid receptor-related orphan receptor gamma (RORγ)-selective inverse agonists with a phenanthridin-6(5H)-one skeleton from a liver X receptor ligand.
    Nishiyama Y; Nakamura M; Misawa T; Nakagomi M; Makishima M; Ishikawa M; Hashimoto Y
    Bioorg Med Chem; 2014 May; 22(9):2799-808. PubMed ID: 24702856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.